Skip to content

DATURA

Determination of Adequate TUberculosis Regimen in Adults and adolescents hospitalised with HIV-associated severe immune suppression – NCT04738812

DATURA
Menu

Primary menu

  • Home
  • About
    • More about DATURA
    • DATURA project governance
    • Work Packages
      • WP5 Training and capacity building
      • WP6 Communication, dissemination and policy
    • Funding
  • Partners
    • Clinical sites
      • Cambodia
      • Cameroon
      • Guinea
      • Uganda
      • Vietnam
      • Zambia
  • Participants
    • Boubacar Djelo Diallo
    • Charles Kouanfack
    • Conrad K. Muzoora
    • Dang Thi Minh HÀ
    • Didier Laureillard
    • François-Xavier Blanc
    • Gilles Peytavin
    • Jean-Pierre Molès
    • John Tembo
    • Kondwelani John Mateyo
    • Maryline Bonnet
    • Nguyen Duc BANG
    • Nicolas Nagot
    • Ricky Heggheim
    • Sven Gudmund Hindraker
    • For participants
      • Datura documents
  • Trial Info
    • Hypothesis, Objectives, Study Design
    • Inclusion / non-inclusion criteria
    • Treatment details
    • Adherence
    • Randomisation
    • About TB and HIV/AIDS
  • Resources
  • Contact

All African trial sites have completed their first patient enrolment

Posted on 24/08/2022 by rhe001

It is with great pleasure to announce that all of the four trial sites in Africa have started to enroll patients in the DATURA program. The trial sites are located in Guinea, Cameroon, Zambia and Uganda. The latter received its Continue reading All African trial sites have completed their first patient enrolment→

Posted in Mission, News

First DATURA participant enrolled in Ignace Deen Hospital in Guinea

Posted on 13/05/2022 by rhe001

  BREAKING NEWS: The first DATURA participant was enrolled in Ignace Deen Hospital, Conakry, Guinea on April 21st 2022. It is a 25-years old woman who just discovered her HIV status with CD4 count of 67 cells/µL. She has been Continue reading First DATURA participant enrolled in Ignace Deen Hospital in Guinea→

Posted in Mission, News

DATURA Mission to Guinea, Conakry – July 05-09th, 2021

Posted on 23/09/2021 by gmset

The visiting team was composed of Hicham ABOUINAN, international data manager, Jean-Pierre MOLES, laboratory coordinator, and Catherine QUILLET, international project manager, from the international coordinating trial unit. The Guinea team was led by Boubacar Djelo DIALLO, principal investigator, and Lansana Continue reading DATURA Mission to Guinea, Conakry – July 05-09th, 2021→

Posted in Mission, News

2nd DATURA Project Steering Committee : 4th October 2021

Posted on 21/09/2021 by gmset

Taking advantage of the fact that many DATURA investigators will be participating in the  Afrique -France summit venue in Montpellier, 7-9 October, we have organised the 2nd DATURA Project Steering Committee (PSC) on 4 Oct. In last year’s DATURA PSC Continue reading 2nd DATURA Project Steering Committee : 4th October 2021→

Posted in Meetings

EDCTP update June 2021

Posted on 09/07/2021 by gmset

EDCTP annual report 2020 published EDCTP’s Annual Report 2020 summarises the activities of the Partnership in 2020, shows the steady growth, scope and cohesion of the project portfolio, and highlights the progress made towards the objectives of the programme. Tenth Continue reading EDCTP update June 2021→

Posted in EDCTP

Upcoming DATURA meetings

Posted on 09/07/2021 by gmset

Posted in Meetings

Latest travel information for DATURA partners

Posted on 03/06/2021 by gmset

last updated: 18.5.21 **this information changes constantly – check with the relevant authorities Cambodia: travellers must present a negative PCR <72 hours + 2-week quarantine Cameroon: travellers must present a negative PCR <72 hours France: restrictions and requirements in FR Continue reading Latest travel information for DATURA partners→

Posted in News, Participants

Post navigation

← Older posts

Primary Sidebar Widget Area

DATURA – a clinical trial

DATURA addresses people who are co-infected with TB and HIV. It is a research project that aims to assess whether an intensified initial TB treatment could increase survival in hospitalised, HIV-infected adults and adolescents compared to the standard TB treatment regime.

DATURA is registered in ClinicalTrials.gov : NCT04738812

  • Learn more key facts about TB & HIV – 2 often inter-linked global health challenges 
  • Why is DATURA undertaking this research?
  • DATURA Work Packages

Who is who in DATURA?

  • List of participants by role in project
  • Clinical sites
  • Participants listed by Work Project
  • Partner Institutions

Governance meetings

  • Project Executive meeting: 1 meeting every 3 months. Next on December 20th, 2022
  • Project Steering Committee: 1 meeting per year. Next on November or December, 2022
  • Data and Safety Monitoring Board meeting: the first meeting after the start of inclusions will be on October 24th, 2022

 

Important DATURA dates:

  • The European and Developing Countries Clinical Trials Partnership (EDCTP)signed the Grant 14 April 2020.
  • Official starting date of the project period is 1 May 2020. The project will last for 54 months from this date.
  • DATURA kick-off 14-15 Sept. 2020
  • First participant enrolled on April 21st, 2022.
  • All African sites recruiting by August 2022.
  • EDCTP grant extended for an additional 14 months until December 2025.

TB Day

24 March – mark your calendar!

HIV Day

1 December – mark your calendar!

Recent Posts

  • All African trial sites have completed their first patient enrolment
  • First DATURA participant enrolled in Ignace Deen Hospital in Guinea
  • DATURA Mission to Guinea, Conakry – July 05-09th, 2021

Categories

  • EDCTP
  • Meetings
  • Mission
  • News
  • other
  • Participants
  • publications
Copyright © 2023 DATURA. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up